Getinge Full Year Report 2020: Intense efforts to support health care and pharmaceutical companies
“We have continued to support health care, and the pharmaceutical companies that are rapidly developing and manufacturing COVID-19 vaccines”, says Mattias Perjos, President & CEO at Getinge. “We also achieved our full-year target of delivering 26,000 advanced ICU ventilators, and the demand for our ECMO therapy products remains high”.During the fourth quarter Getinge also noted a strong order intake in Sterile Transfer linked to COVID-19 vaccine manufacturing, for delivery in 2021. A large part of the business continues to be negatively affected by COVID-19 due to cancelled or postponed